News and Trends 9 Feb 2023
Icosagen receives €18M loan for R&D and new facility
The Estonian biopharma company Icosagen AS has reached an €18 million financing agreement with the European Investment Bank (EIB) backed by the InvestEU program. The funds will strengthen the company’s…